Results 151 to 160 of about 3,216,105 (293)

Phytochemical Screening and in vivo antioxidant activity of Ethanolic extract of caesalpinia bondus (L.) Roxb [PDF]

, 2012
Phytochemical screening, antioxidant activity in vivo and lipid peroxidation of 75 % ethanolic extract of young twigs and leaves of Caesalpinia bonduc were carried out by chemical test, and assessment of catalase and peroxidase activities and lipid ...
Akindahunsi , A. A, Ntube , C. A, Ogunlana , O. E, Ogunlana , O. O, Olagunju , J. A   +4 more
core   +1 more source

2. Antirheumatic Agents, 2) Biological Agents

, 2012
Koichi Amano
openalex   +2 more sources

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS

, 2017
А. А. Abramkin, Т. А. Lisitsyna, D. Veltishchev, O. Seravina, O. Kovalevskaya, Е. Л. Насонов   +5 more
openalex   +2 more sources

Erratum to: Optimum use of disease-modifying and immunosuppressive antirheumatic agents during pregnancy and lactation [PDF]

, 1996
Rosalind Ramsey‐Goldman, Ellen Van Obberghen‐Schilling   +1 more
openalex   +1 more source

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

, 2014
Döndü Üsküdar Cansu, Sabri Güncan, Nazife Şule Yaşar Bilge, Timuçin Kaşifoğlu, Cengiz Korkmaz   +4 more
openalex   +2 more sources

The Prevalence of Hypersensitivity Reactions to Antirheumatic Biological Agents and Results of the Skin Tests: Experience of a Tertiary Referral Allergy Center in Turkey

, 2020
Ceyda Tunakan Dalgıç, Figen Yargucu Zihni, Gökten Bulut, Ali Kokuludağ, Aytül Sin   +4 more
openalex   +2 more sources

NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS

Научно-практическая ревматология, 2016
Despite major advances in the management of rheumatoid arthritis (RA), whicare associated with the development of new methods for its early diagnosis, the clinical introduction of a wide range of innovative medications and particularly the improvement of
E. L. Nasonov
doaj  

Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis

, 2018
Yu. V. Muraviev, G. I. Gridneva, L. A. Muravieva, N. V. Muravieva, A. V. Alexeeva, К. S. Nurbaeva, K. M. Mikhailov, A. V. Rozov   +7 more
openalex   +2 more sources

A Practical Procedure for the Synthesis of Esonarimod, (R,S)-2-Acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic Acid, an Antirheumatic Agent. (Part 1).

, 2002
Toshiya Noguchi, Akira Onodera, Kazuyuki Tomisawa, Sadakazu Yokomori   +3 more
openalex   +2 more sources

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

, 2011
Stefania Zingarelli, Paolo Airò, Micol Frassi, Chiara Bazzani, Mirko Scarsi, Massimo Puoti   +5 more
openalex   +2 more sources